Impact of epigenetic reprogramming on antitumor immune responses in glioma

BL McClellan, S Haase, FJ Nunez… - The Journal of …, 2023 - Am Soc Clin Investig
Epigenetic remodeling is a molecular hallmark of gliomas, and it has been identified as a
key mediator of glioma progression. Epigenetic dysregulation contributes to gliomagenesis …

[HTML][HTML] Understanding cancer stem cells and plasticity: Towards better therapeutics

NM Warrier, N Kelkar, CT Johnson… - European Journal of …, 2023 - Elsevier
The ability of cancer cells to finally overcome various lines of treatment in due course has
always baffled the scientific community. Even with the most promising therapies, relapse is …

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

B Zhao, J Wu, H Li, Y Wang, Y Wang, H Xing… - Cell Communication and …, 2023 - Springer
Glioblastoma (GBM) is the most malignant CNS tumor with a highest incidence rate, and
most patients would undergo a recurrence. Recurrent GBM (rGBM) shows an increasing …

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma

ZY Liu, T Lan, F Tang, YZ He, JS Liu, JZ Yang, X Chen… - Bmc Cancer, 2023 - Springer
Background Glioma is the most common and aggressive tumor in the adult brain. Recent
studies have indicated that Zinc finger DHHC-type palmitoyltransferases (ZDHHCs) play …

Contribution of immune cells to cancer-related neuropathic pain: an updated review

H Ma, Z Pan, B Lai, M Li, J Wang - Molecular Pain, 2023 - journals.sagepub.com
Given that the incidence of cancer is dramatically increasing nowadays, cancer-related
neuropathic pain including tumor-related and therapy-related pain gradually attracts more …

[HTML][HTML] A mini-review-cancer energy reprogramming on drug resistance and immune response

C Liu, L Yang, T Gao, X Yuan, O Bajinka, K Wang - Translational Oncology, 2024 - Elsevier
With the growing interest to harness cancer metabolism and energy reprogramming, this
mini review aimed to explain the metabolic programming revealing the mechanisms …

[HTML][HTML] Long noncoding RNA HOXC-AS3 remodels lipid metabolism and promotes the proliferation of transformed macrophages in the glioma stem cell …

Y Sheng, B Chen, L Liu, S Li, S Huang, S Cheng, Z Li… - Heliyon, 2023 - cell.com
Metabolism remodelling of macrophages in the glioblastoma microenvironment contributes
to immunotherapeutic resistance. However, glioma stem cell (GSC)-initiated lipid …

Proton pump inhibitors display anti‐tumour potential in glioma

B Li, Y Liu, S Sun - Cell Proliferation, 2023 - Wiley Online Library
Objectives Glioma is one of the most aggressive brain tumours with poor overall survival
despite advanced technology in surgical resection, chemotherapy and radiation …

Microarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer

J Liu, H Yang, P Li, Y Zhou, Z Zhang, Q Zeng… - Scientific Reports, 2024 - nature.com
Etoposide is a second-line chemotherapy agent widely used for metastatic colorectal
cancer. However, we discovered that etoposide treatment induced greater motility potential …

The importance of the circRNA/Wnt axis in gliomas: biological functions and clinical opportunities

N Hedayati, A Mafi, A Farahani, M Hashemi… - … -Research and Practice, 2024 - Elsevier
Gliomas are among the most common cancers in the central nervous system, arising
through various signaling pathways. One significant pathway is Wnt signaling, a tightly …